Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v4-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-01-04 | 2023-01-04 |
| Drug Identification Number | 02474522 | 02474522 |
| Brand name | TRELEGY ELLIPTA | TRELEGY ELLIPTA |
| Common or Proper name | fluticasone furoate, umeclidinium and vilanterol dry powder for oral inhalation | fluticasone furoate, umeclidinium and vilanterol dry powder for oral inhalation |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | VILANTEROL UMECLIDINIUM FLUTICASONE FUROATE | VILANTEROL UMECLIDINIUM FLUTICASONE FUROATE |
| Strength(s) | 25MCG 62.5MCG 100MCG | 25MCG 62.5MCG 100MCG |
| Dosage form(s) | POWDER | POWDER |
| Route of administration | INHALATION INHALATION | INHALATION INHALATION |
| Packaging size | 1x30 | 1x30 |
| ATC code | R03AL | R03AL |
| ATC description | ||
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | ||
| Actual start date | 2022-12-12 | 2022-12-12 |
| Estimated end date | 2023-01-06 | 2023-01-06 |
| Actual end date | 2023-01-03 | 2023-01-03 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Managing supply due to high demand. | Managing supply due to high demand. |
| Health Canada comments |